Dr. Evie Hobbs, MD
Claim this profileOHSU Knight Cancer Institute
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
16 drugs studied
Area of expertise
1Breast Cancer
ER positive
HER2 negative
Stage IV
2Breast Cancer
Stage IV
ER positive
PR positive
Affiliated Hospitals
Clinical Trials Evie Hobbs, MD is currently running
Combination Therapy
for Triple Negative Breast Cancer
This phase II study assesses the efficacy of the combination of olaparib with durvalumab, selumetinib, or capivasertib or ceralasertib alone in the treatment of patients with metastatic triple negative breast cancer (TNBC). Olaparib may stop growth of tumor cells by inhibiting some of the enzymes (ADP ribose polymerase \[PARP\]) needed for cell growth. Durvalumab, a monoclonal antibody, inhibits the growth and spread of tumors by stimulating the patient's antitumor immune response. Selumetinib, capivasertib, and ceralasertib are inhibitor drugs that may stop the growth of tumor cells by blocking some of the enzymes (MEK, AKT, ATR) needed for cell growth. Giving olaparib together with durvalumab, selumetinib, or capivasertib or giving ceralasertib alone may provide an effective method to treat patients with metastatic triple negative breast cancer.
Recruiting1 award Phase 215 criteria
Personalized Adaptive Novel Agents
for Breast Cancer
This trial is testing new medicines along with regular cancer treatment to find the best combinations for breast cancer patients. It focuses on identifying which treatments work best based on specific cancer characteristics. Early signs of success are monitored using MRI scans and tests on blood and tissue samples.
Recruiting1 award Phase 216 criteria
More about Evie Hobbs, MD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Evie Hobbs, MD has experience with
- Abemaciclib
- Niraparib Tosylate Monohydrate
- Capivasertib
- Ceralasertib
- Durvalumab
- Olaparib
Breakdown of trials Evie Hobbs, MD has run
Breast Cancer
Breast cancer
Gastroesophageal Junction Adenocarcinoma
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Evie Hobbs, MD specialize in?
Evie Hobbs, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are HER2 negative.
Is Evie Hobbs, MD currently recruiting for clinical trials?
Yes, Evie Hobbs, MD is currently recruiting for 2 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Evie Hobbs, MD has studied deeply?
Yes, Evie Hobbs, MD has studied treatments such as Abemaciclib, Niraparib Tosylate Monohydrate, Capivasertib.
What is the best way to schedule an appointment with Evie Hobbs, MD?
Apply for one of the trials that Evie Hobbs, MD is conducting.
What is the office address of Evie Hobbs, MD?
The office of Evie Hobbs, MD is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.